These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30635947)

  • 21. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
    Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
    Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.
    Liu YH; Han YL; Song J; Wang Y; Jing YY; Shi Q; Tian C; Wang ZY; Li CP; Han J; Dong XP
    Int J Biochem Cell Biol; 2011 May; 43(5):768-74. PubMed ID: 21296677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STI571 protects neuronal cells from neurotoxic prion protein fragment-induced apoptosis.
    Pan Y; Sun L; Wang J; Fu W; Fu Y; Wang J; Tong Y; Pan B
    Neuropharmacology; 2015 Jun; 93():191-8. PubMed ID: 25681617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion protein at the crossroads of physiology and disease.
    Biasini E; Turnbaugh JA; Unterberger U; Harris DA
    Trends Neurosci; 2012 Feb; 35(2):92-103. PubMed ID: 22137337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion disease: a deadly disease for protein misfolding.
    Chakraborty C; Nandi S; Jana S
    Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
    Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
    J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.
    Giaccone G; Verga L; Bugiani O; Frangione B; Serban D; Prusiner SB; Farlow MR; Ghetti B; Tagliavini F
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9349-53. PubMed ID: 1357663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
    Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.
    Piccardo P; Liepnieks JJ; William A; Dlouhy SR; Farlow MR; Young K; Nochlin D; Bird TD; Nixon RR; Ball MJ; DeCarli C; Bugiani O; Tagliavini F; Benson MD; Ghetti B
    Am J Pathol; 2001 Jun; 158(6):2201-7. PubMed ID: 11395398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural diversity and initial oligomerization of PrP106-126 studied by replica-exchange and conventional molecular dynamics simulations.
    Ning L; Guo J; Bai Q; Jin N; Liu H; Yao X
    PLoS One; 2014; 9(2):e87266. PubMed ID: 24586266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
    Roettger Y; Zerr I; Dodel R; Bach JP
    PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicity of a prion protein fragment.
    Forloni G; Angeretti N; Chiesa R; Monzani E; Salmona M; Bugiani O; Tagliavini F
    Nature; 1993 Apr; 362(6420):543-6. PubMed ID: 8464494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.
    Parchi P; Chen SG; Brown P; Zou W; Capellari S; Budka H; Hainfellner J; Reyes PF; Golden GT; Hauw JJ; Gajdusek DC; Gambetti P
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8322-7. PubMed ID: 9653185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid associated proteins in Alzheimer's and prion disease.
    Veerhuis R; Boshuizen RS; Familian A
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hetero-oligomeric Amyloid Assembly and Mechanism: Prion Fragment PrP(106-126) Catalyzes the Islet Amyloid Polypeptide β-Hairpin.
    Ilitchev AI; Giammona MJ; Olivas C; Claud SL; Lazar Cantrell KL; Wu C; Buratto SK; Bowers MT
    J Am Chem Soc; 2018 Aug; 140(30):9685-9695. PubMed ID: 29989407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.